CVS Health combines pharmacy retail, pharmacy benefits management, and health insurance. Its businesses include CVS Pharmacy stores, Caremark prescription benefit services, and Aetna health plans, together with healthcare delivery initiatives. Revenue spans prescription dispensing, insurance premiums, administrative fees, and other healthcare services, with results sensitive to medical and pharmacy cost trends.
CVS Health Corp. (CVS) has a MarketKingdoms composite score of 64.1 (B), an B-range rating. It ranks 912th of 1,866 covered companies, 41st of 78 in Healthcare (sector average 64.4) and 3rd of 6 in Healthcare Plans. Scores as of 2026-10-26.
Its strongest lenses are KPI momentum at 93 (Healthcare average 78) and Price (valuation) at 85 (Healthcare average 50). Its weakest lenses are Quality (profitability) at 26 (sector average 50) and Trend (momentum) at 37 (sector average 50).
| Lens | Type | CVS | Healthcare average | Healthcare Plans average | Percentile in sector |
|---|---|---|---|---|---|
| Industry opportunity | Research signal | 73 | 81 | 73 | 8th |
| Stock selection | Research signal | 82 | 79 | 76 | 69th |
| KPI momentum | Research signal | 93 | 78 | 72 | 94th |
| Catalyst watch | Research signal | 73 | 74 | 72 | 41st |
| Price (valuation) | Fundamental lens | 85 | 50 | 72 | 95th |
| Expansion (growth) | Fundamental lens | 43 | 50 | 42 | 36th |
| Quality (profitability) | Fundamental lens | 26 | 50 | 27 | 15th |
| Trend (momentum) | Fundamental lens | 37 | 50 | 57 | 33rd |
The most recent call analysed was held on 2026-08-05 (fiscal 2026 Q2). MarketKingdoms checks what management promised on each call against what it later delivered.
The stock's valuation gap is -15.6%: its price is well below the path its market, sector and industry moves explain (strongly undervalued versus the model path). Factor sensitivity: market beta 0.25, sector beta -0.08, industry beta 0.69; the factor model explains 30% of its moves (R²).
| Company | Composite | Grade | Valuation gap |
|---|---|---|---|
| Humana Inc. (HUM) | 65.0 | B | +7.2% |
| Elevance Health Inc. (ELV) | 64.4 | B | -5.5% |
| Cigna Group (CI) | 63.4 | B- | +2.5% |
| UnitedHealth Group Inc. (UNH) | 63.3 | B- | +3.7% |
| Centene Corp. (CNC) | 62.4 | B- | -11.2% |
CVS Health Corp. financial statements · Healthcare sector ranking · Healthcare Plans industry ranking · All covered companies
The composite score (0–100, graded A+ to D-) blends research signals from each earnings call with fundamental lenses from SEC filings and market prices. Research signals: Industry opportunity, Stock selection, KPI momentum and Catalyst watch, read from what management said and whether it delivered. Fundamental lenses: Price (valuation), Expansion (growth), Quality (profitability) and Trend (momentum). Scores are recalculated every night and after every earnings call. The valuation gap compares the actual price path with the path the stock's market, sector and industry moves explain; it is a model comparison, not a fair-value estimate.
General information, not investment advice.